Delivery Order W81K0018D0010-W81K0020F0149

Award Date 10/1/20
Potential Completion Date 9/30/21
Potential Value $1.7M
Federal Agency
Medical Command
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Castleton, IN 46256, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of the Army Medical Command awarded Roche Diagnostics Corporation a $640,000 firm fixed price delivery order for histology testing services in support of the Department of Pathology and Area Laboratory Services at Brooke Army Medical Center located at Joint Base San Antonio Fort Sam Houston, Texas. The delivery order, issued under an unspecified government-wide acquisition contract, requires Roche Diagnostics to provide histology testing for the medical center from October 1, 2020...
This is a delivery order awarded to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, by the Department of the Army Medical Command. The $2,899,099.26 firm-fixed-price contract provides clinical chemistry and immunoassay testing services to the Brooke Army Medical Center and outlying clinics at Joint Base San Antonio-Fort Sam Houston, Texas for Fiscal Year 2020. Roche Diagnostics has held multiple General Services Administration schedule contracts...
This is a delivery order awarded by the Department of the Army Medical Command to Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services. The $1,280,000 firm-fixed-price contract is for histology testing services at the Brooke Army Medical Center in JBSA Fort Sam Houston, Texas for Fiscal Year 2020. The contract has no set-aside designation. Roche Diagnostics has a history of providing critical...
Roche Diagnostics Corporation was awarded a $2,049,995.92 firm fixed price delivery order against an existing contract vehicle to provide CORE LAB:IMMUNOASSAY TESTING CPRR services for the Department of the Army Medical Command. The delivery order, which has no set-aside designation, will support option year requirements and increased quantities through a period of performance ending September 30, 2023. The location of performance will be in Castleton, Indiana. Roche Diagnostics, doing...
The Department of the Army Medical Command awarded Roche Diagnostics Corporation a $1.9 million firm fixed price delivery order against an unspecified contract vehicle to provide CORE LAB:IMMUNOASSAY TESTING CPRR services. Roche will deliver immunology laboratory testing and analysis at its facility in Castleton, Indiana through September 2022 in support of the Army Medical Command's medical research and healthcare programs. No subcontractors or set aside designations were identified. This...
Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, has been awarded a firm fixed price delivery order against an existing contract vehicle to provide laboratory detection kits to the Defense Health Agency. The $385,588.62 contract has no set-aside designation and requires completion by December 6, 2023. Roche will supply the kits from its location in San Diego, California in support of the Defense Health Agency's medical laboratory capabilities at military treatment...
The Department of the Army Medical Command awarded Roche Diagnostics Corporation, a manufacturer and distributor of in vitro diagnostics, a $123,839.79 firm fixed-price delivery order contract to provide medical laboratory kits for the Brooke Army Medical Center. The contract, which does not have a set-aside designation, was issued under Roche's General Services Administration (GSA) Schedule contract for critical laboratory analyzers and equipment. Roche has previously received awards from...
The Department of the Army Medical Command awarded a firm fixed-price delivery order contract to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The $1,280,000.00 contract is for histology cost-per-test services to be provided to the Brooke Army Medical Center, with a completion date of September 30, 2018. Roche Diagnostics has provided similar medical equipment and supplies to various federal agencies through...
Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, was awarded a firm fixed price purchase order by the Department of the Army Medical Command for $7,625,850 to provide INFL A/B without a set-aside designation. Performance will occur in Castleton, Indiana through September 30, 2023. As a manufacturer and distributor of in vitro diagnostics, reagents, laboratory instruments, and associated products and services, Roche will likely supply critical care analyzers, reagents,...
This federal contract was awarded by the Department of the Army Medical Command to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a manufacturer and distributor of in vitro diagnostics and associated products and services. The $132,817.68 firm-fixed-price purchase order is for the delivery of ROCHE COBAS products and services. The contract has no set-aside designation and was awarded on October 1, 2019 with a completion date of October 31, 2020. Roche Diagnostics has...
  • W81K0018D0010
    Indefinite Delivery Contract
  • W81K0018D0010-W81K0020F0149
    Delivery Order

Roche Diagnostics Corporation has been awarded a $1.7 million delivery order by the Department of the Army Medical Command to provide clinical chemistry and immunoassay testing services to Brooke Army Medical Center in San Antonio, Texas. The firm fixed price order, which runs from October 2020 through September 2021, calls for Roche to conduct laboratory analysis in support of pathology and clinical services at the military treatment facility. As the prime contractor, Roche will leverage its expertise in diagnostic solutions and experience serving Department of Defense medical needs on this contract. No subcontractors or special designations were identified.

Generated 12/25/23, 7:06 AM